DNA ligase is an enzyme essential for DNA replication, repair and recombination in all organisms [1][2][3]. The enzyme catalyzes the formation of phosphodiester bonds at single-strand breaks in duplex DNA during these physiological processes [1][2][3]. There are two classes of DNA ligases, identified on the basis of their cofactor requirements. Bacterial DNA ligases involved in DNA replication utilize NAD + as a cofactor, whereas mammalian and viral DNA ligases require ATP for activity [1][2][3]. Biochemical studies of bacterial DNA ligase (NAD + -dependent), and viral and human DNA ligases (ATP-dependent) have established that the mechanism of the reactions catalyzed by the two different groups of DNA ligases is similar [1][2][3]. The reaction mechanism consists of three reversible steps: (a) adenylation of the enzyme by transferring the adenylate group from NAD + or ATP to the e-NH 2 group of Lys in the enzyme with the release of nicotinamide + and specifically inhibits enzyme adenylation, but not DNA adenylation or ligation. Labeling studies establish that this molecule inhibits the incorporation of thymidine into DNA and that overexpression of DNA ligase in the cell abolishes this inhibition. Finally, microbiological studies show that this molecule exhibits a broad spectrum of antibacterial activity. Together, this study shows that this small molecule inhibitor identified is specific to bacterial NAD + -dependent DNA ligases, exhibits a broad spectrum of antibacterial activities, and has the potential to be developed into an antibacterial agent.Abbreviations DDPP, 2,4-diamino-7-dimethylamino-pyrimido [4,5-d]pyrimidine; FRET, fluorescence resonance energy transfer; NMN, nicotinamide mononucleotide.